SE7609245L - Forfarande for framstellning av dopaminderivat - Google Patents

Forfarande for framstellning av dopaminderivat

Info

Publication number
SE7609245L
SE7609245L SE7609245A SE7609245A SE7609245L SE 7609245 L SE7609245 L SE 7609245L SE 7609245 A SE7609245 A SE 7609245A SE 7609245 A SE7609245 A SE 7609245A SE 7609245 L SE7609245 L SE 7609245L
Authority
SE
Sweden
Prior art keywords
dopamin
derivatives
procedure
preparation
isoleucine
Prior art date
Application number
SE7609245A
Other languages
English (en)
Swedish (sv)
Inventor
N Yanaihara
T Igarashi
Y Kunii
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50100623A external-priority patent/JPS5811853B2/ja
Priority claimed from JP51004022A external-priority patent/JPS5858342B2/ja
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of SE7609245L publication Critical patent/SE7609245L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052Val-amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7609245A 1975-08-21 1976-08-19 Forfarande for framstellning av dopaminderivat SE7609245L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50100623A JPS5811853B2 (ja) 1975-08-21 1975-08-21 ドパミンユウドウタイノゴウセイホウ
JP51004022A JPS5858342B2 (ja) 1976-01-19 1976-01-19 ドパミン誘導体およびドパミン誘導体を含有する医薬

Publications (1)

Publication Number Publication Date
SE7609245L true SE7609245L (sv) 1977-02-22

Family

ID=26337719

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7609245A SE7609245L (sv) 1975-08-21 1976-08-19 Forfarande for framstellning av dopaminderivat

Country Status (7)

Country Link
US (1) US4064235A (https=)
DE (1) DE2637600A1 (https=)
ES (1) ES450874A1 (https=)
FR (1) FR2321297A1 (https=)
GB (1) GB1562608A (https=)
NL (1) NL186863C (https=)
SE (1) SE7609245L (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592552A (en) * 1976-12-10 1981-07-08 Inst Nat Sante Rech Med Pseudopeptides used as medicaments
US4113715A (en) * 1977-01-17 1978-09-12 E. R. Squibb & Sons, Inc. Amino acid derivatives
US4179434A (en) * 1977-01-17 1979-12-18 E. R. Squibb & Sons, Inc. Amino acid derivatives
US4165320A (en) * 1977-01-17 1979-08-21 E. R. Squibb & Sons, Inc. Amino acid derivatives
PH14064A (en) * 1977-05-06 1981-01-26 Pfizer Phenylgycine derivatives,pharmaceutical compositions and method of use
DE3685840D1 (de) 1985-04-30 1992-08-06 Dresden Arzneimittel 3-cyan-pyridine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US7105486B2 (en) * 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
US7700561B2 (en) * 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
US7659253B2 (en) 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
SI1644019T2 (en) * 2003-05-29 2018-04-30 Shire Llc Abuse resistant amphetamine compounds
SG11202101817UA (en) 2018-09-13 2021-03-30 Univ Canberra Methods of inhibition
CN111925293B (zh) * 2020-08-24 2022-06-14 山东达冠医药科技有限公司 一种盐酸多巴胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803120A (en) * 1971-09-28 1974-04-09 Hoffmann La Roche Di-and tripeptides of 3-(3,4-dihydroxyphenyl)-alanine

Also Published As

Publication number Publication date
NL186863C (nl) 1991-03-18
DE2637600C2 (https=) 1988-01-28
NL186863B (nl) 1990-10-16
FR2321297B1 (https=) 1979-05-18
NL7609368A (nl) 1977-02-23
GB1562608A (en) 1980-03-12
FR2321297A1 (fr) 1977-03-18
US4064235A (en) 1977-12-20
DE2637600A1 (de) 1977-03-03
ES450874A1 (es) 1977-12-01

Similar Documents

Publication Publication Date Title
SE7609245L (sv) Forfarande for framstellning av dopaminderivat
NO150397C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive acylderivater av aminosyrer
SE7902401L (sv) Ornitin- och argininsalter
SE8004745L (sv) Nya tripeptider, som inverkar pa det centrala nervsystemet, jemte sett for deras framstellning
SE7608092L (sv) Nya steroider
ES447011A1 (es) Procedimiento para preparar 1,1,1,-triaril-alquilaminas.
ES466851A1 (es) Procedimiento para la preparacion de 2-bromo-6-fluor-n-2- imidazolidinilidenbenzamina.
SE7411243L (https=)
DE3360386D1 (de) Aminoalkadiene derivative
SE7609495L (sv) N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav
ES471793A1 (es) Un procedimiento para preparar peptidos
ES8100015A1 (es) Procedimiento para la preparacion de nuevos derivados de 2-(4-aminopiperidino)-3,4-dihidroquinoleina.
JPS5289629A (en) Dopamine derivatives and medicaments containing the same
ES445144A1 (es) Procedimiento para la preparacion de compuestos derivados deindolobenzacepinas.
ES424931A1 (es) Un procedimiento de preparacion de piroglutamato de argini-na.
FI832622A0 (fi) Homocykliska derivat
GB1243474A (en) Compositions comprising l-dopa
GB1565412A (en) Sulphur-containing n-(o-nitro-benzyl)-amino acids and esters
ES8304924A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido glutamil-diaminopimelico que contiene una b-lactama.
DE3261643D1 (en) New peptide, process for preparation thereof and use thereof
ES457576A3 (es) Un procedimiento para la preparacion de 2-fluorometil-3-(o- tolil)-6-amino-4(3h) quinazolinona.
DK151261C (da) Fremgangsmaade til fremstilling af 17s,17's-bisspartein eller fysiologisk acceptable syreadditionssalte deraf
ES401511A1 (es) Procedimiento para la preparacion de tripeptidos.
ES394974A1 (es) Procedimiento para la preparacion de una composicion herbi-cida que contiene como ingrediente activo un derivado de a- lanina n,n-disustituida.
GB2011909A (en) Synthetic Analogue of Bradykinin

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7609245-1